This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gao, H.-B. Articles by Hardy, M. P. Search for Related Content PubMed PubMed Citation Articles by Gao, H.-B. Articles by Hardy, M. P.

Glucocorticoid Induces Apoptosis in Rat Leydig Cells

Laboratory of Reproductive Biology, Shanghai Second Medical University (H.-B.G., M.-H.T., Y.-Q.H., Q.-S.G.), Shanghai, People’s Republic of China; and The Population Council (R.G., M.P.H.) and Rockefeller University (M.P.H.), New York, New York 10021

Address all correspondence and requests for reprints to: Dr. Matthew P. Hardy, The Population Council, 1230 York Avenue, New York, New York 10021. E-mail: m-hardy{at}popcbr.rockefeller.edu

The aim of the present study was to investigate whether glucocorticoid induces apoptosis in rat Leydig cells. To determine whether there are developmental differences in glucocorticoid sensitivity, Leydig cells were isolated at distinct stages of their differentiation [mesenchymal-like progenitors (PLC), immature Leydig cells (ILC), and adult Leydig cells (ALC)] from 21-, 35-, and 90-d-old Sprague Dawley rats, respectively. Glucocorticoid induction of apoptosis was evaluated after both in vitro and in vivo exposures. In the first set of experiments, PLC, ILC, and ALC were treated with 100 nM corticosterone (CORT) for either 4 or 24 h in vitro and then assessed for labeling with the apoptotic marker annexin V. PLC exposed to CORT had levels of annexin V-fluorescein isothiocyanate labeling that were unchanged relative to control values at both time points (P > 0.05). In contrast, CORT-treated ILC and ALC had increased frequencies of apoptosis: in ALC, a 22.1 ± 1.7% incidence after 4 h and 30.5 ± 2.3% after 24 h compared with 7.4 ± 0.8% in untreated controls (P < 0.05). Similar trends were observed for ILC. Ultrastructural analysis confirmed that the increase in annexin V labeling was associated with characteristic signs of apoptosis, including nuclear fragmentation and formation of apoptotic bodies. A second line of experiments examined whether apoptosis was evident in purified Leydig cells after administration of CORT in vivo. Male rats were subjected to bilateral adrenalectomy and were treated with CORT by ip injection twice daily at doses ranging from 2.5–7.5 mg/100 g BW starting 3 d after surgery. The frequency of Leydig cell apoptosis was measured at 12, 24, 48, and 72 h after the first injection. Administration of the 2.5-mg dose raised circulating CORT 5–10 times above normal basal concentrations, and LH levels sampled at these times were not altered in the treated animals. Increased Leydig cell apoptosis was measurable after 24 h of treatment, with an incidence of 21.1 ± 1.8% in ALC compared with 5.7 ± 0.8% in untreated controls (P < 0.05). Sharp reductions in immunocytochemical staining intensity were observed in the treated animals for a Leydig cell marker, 11ß-hydroxysteroid dehydrogenase, which occurred concurrently with decreased serum T levels. This was consistent with the hypothesis that CORT-mediated induction of apoptosis leads to declines in Leydig cell numbers, thereby affecting T production. These results suggest that excessive exposure to CORT initiates apoptosis in rat Leydig cells, potentially contributing to suppression of circulating T levels during stress and other conditions in which glucocorticoid concentrations are elevated.

This article has been cited by other articles:

				L. J Martin and J. J Tremblay Glucocorticoids antagonize cAMP-induced Star transcription in Leydig cells through the orphan nuclear receptor NR4A1 J. Mol. Endocrinol., September 1, 2008; 41(3): 165 - 175. [Abstract] [Full Text] [PDF]

				J.-Y. Chung, J. Y. Kim, Y.-J. Kim, S. J. Jung, J.-E. Park, S. G. Lee, J. T. Kim, S. Oh, C. J. Lee, Y.-D. Yoon, et al. Cellular Defense Mechanisms against Benzo[a]pyrene in Testicular Leydig Cells: Implications of p53, Aryl-Hydrocarbon Receptor, and Cytochrome P450 1A1 Status Endocrinology, December 1, 2007; 148(12): 6134 - 6144. [Abstract] [Full Text] [PDF]

				V. L. Williams, A. DeGuzman, H. Dang, M. Kawaminami, T. W. C. Ho, D. G. Carter, and A. M. Walker Common and specific effects of the two major forms of prolactin in the rat testis Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1795 - E1803. [Abstract] [Full Text] [PDF]

				J. Del Bravo, A. Catizone, G. Ricci, and M. Galdieri Hepatocyte Growth Factor-Modulated Rat Leydig Cell Functions J Androl, November 1, 2007; 28(6): 866 - 874. [Abstract] [Full Text] [PDF]

				D. G. Satterlee, C. A. Cole, and S. A. Castille Maternal Corticosterone Further Reduces the Reproductive Function of Male Offspring Hatched from Eggs Laid by Quail Hens Selected for Exaggerated Adrenocortical Stress Responsiveness Poult. Sci., March 1, 2007; 86(3): 572 - 581. [Abstract] [Full Text] [PDF]

				Y. Ozaki, M. Higuchi, C. Miura, S. Yamaguchi, Y. Tozawa, and T. Miura Roles of 11{beta}-Hydroxysteroid Dehydrogenase in Fish Spermatogenesis Endocrinology, November 1, 2006; 147(11): 5139 - 5146. [Abstract] [Full Text] [PDF]

				J. Xu, L. Qi, X. Chi, J. Yang, X. Wei, E. Gong, S. Peh, and J. Gu Orchitis: A Complication of Severe Acute Respiratory Syndrome (SARS) Biol Reprod, February 1, 2006; 74(2): 410 - 416. [Abstract] [Full Text] [PDF]

				Q. Dong, A. Salva, C. M. Sottas, E. Niu, M. Holmes, and M. P. Hardy Rapid Glucocorticoid Mediation of Suppressed Testosterone Biosynthesis in Male Mice Subjected to Immobilization Stress J Androl, November 1, 2004; 25(6): 973 - 981. [Abstract] [Full Text] [PDF]

				Z.M. Lei, S. Mishra, P. Ponnuru, X. Li, Z.W. Yang, and Ch.V. Rao Testicular Phenotype in Luteinizing Hormone Receptor Knockout Animals and the Effect of Testosterone Replacement Therapy Biol Reprod, November 1, 2004; 71(5): 1605 - 1613. [Abstract] [Full Text] [PDF]

				J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart 11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response Endocr. Rev., October 1, 2004; 25(5): 831 - 866. [Abstract] [Full Text] [PDF]

				V. G. Martinez, E. H. Pellizzari, E. S. Diaz, S. B. Cigorraga, L. Lustig, B. Denduchis, C. Wolfenstein-Todel, and M. M. Iglesias Galectin-1, a cell adhesion modulator, induces apoptosis of rat Leydig cells in vitro Glycobiology, February 1, 2004; 14(2): 127 - 137. [Abstract] [Full Text] [PDF]

				M. Kusakabe, I. Nakamura, and G. Young 11{beta}-Hydroxysteroid Dehydrogenase Complementary Deoxyribonucleic Acid in Rainbow Trout: Cloning, Sites of Expression, and Seasonal Changes in Gonads Endocrinology, June 1, 2003; 144(6): 2534 - 2545. [Abstract] [Full Text] [PDF]

				Y. Lukyanenko, J.-J. Chen, and J. C. Hutson Testosterone Regulates 25-Hydroxycholesterol Production in Testicular Macrophages Biol Reprod, November 1, 2002; 67(5): 1435 - 1438. [Abstract] [Full Text] [PDF]